Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Aug 20, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001950047-24-006271.pdf
0001950047-24-006271.rtf
Aug 20, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-24-000191.pdf
0001714899-24-000191.rtf
Aug 20, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-24-000193.pdf
0001714899-24-000193.rtf
0001714899-24-000193.xls
Aug 20, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-24-000189.pdf
0001714899-24-000189.rtf
Aug 20, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-24-000192.pdf
0001714899-24-000192.rtf
Aug 16, 2024 SC 13G A statement of beneficial ownership of common stock by certain persons View HTML
0000315066-24-001917.pdf
0000315066-24-001917.rtf
Aug 15, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000177.pdf
0001714899-24-000177.rtf
0001714899-24-000177.xls
Aug 15, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000176.pdf
0001714899-24-000176.rtf
0001714899-24-000176.xls
Aug 13, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-24-000174.pdf
0001714899-24-000174.rtf
Aug 13, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-24-000175.pdf
0001714899-24-000175.rtf
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • …
  • Next page ›
  • Last page »
Displaying 81 - 90 of 710 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use